175 related articles for article (PubMed ID: 11386324)
1. Trade systems in less-developed countries.
Kamal Smith M; 't Hoen E
Lancet; 2001 May; 357(9268):1624. PubMed ID: 11386324
[No Abstract] [Full Text] [Related]
2. Trade systems in less-developed countries.
Nicholson J
Lancet; 2001 May; 357(9268):1624. PubMed ID: 11386325
[No Abstract] [Full Text] [Related]
3. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
't Hoen E
Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
[No Abstract] [Full Text] [Related]
4. Trade deal to curb generic-drug use.
Maxmen A
Nature; 2012 Sep; 489(7414):16-7. PubMed ID: 22962700
[No Abstract] [Full Text] [Related]
5. Affordable drug access for developing countries.
Highleyman L
BETA; 2001; 14(2):12-25. PubMed ID: 11785481
[No Abstract] [Full Text] [Related]
6. Canada to change patent law to allow export of cheap drugs.
Kondro W
Lancet; 2003 Oct; 362(9392):1290. PubMed ID: 14577437
[No Abstract] [Full Text] [Related]
7. World Trade Organization still threatens supply of affordable AIDS drugs.
Hagmann M
Bull World Health Organ; 2002; 80(9):762-3. PubMed ID: 12378300
[No Abstract] [Full Text] [Related]
8. Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity.
Berger JM
Conn J Int Law; 2002; 17(2):157-248. PubMed ID: 12688292
[No Abstract] [Full Text] [Related]
9. . . . and Brazilian AIDS programme threatened by US trade action.
Int J Epidemiol; 2001 Apr; 30(2):413. PubMed ID: 11369751
[No Abstract] [Full Text] [Related]
10. Indian biogenerics industry emerges.
Jayaraman KS
Nat Biotechnol; 2003 Oct; 21(10):1115-6. PubMed ID: 14520378
[No Abstract] [Full Text] [Related]
11. Essential AIDS medications in India.
Thomas J
Issues Med Ethics; 2000; 8(2):62. PubMed ID: 16323350
[No Abstract] [Full Text] [Related]
12. India: New patent law may restrict access to HIV/AIDS treatments.
Cruess G
HIV AIDS Policy Law Rev; 2005 Aug; 10(2):28-30. PubMed ID: 16365971
[TBL] [Abstract][Full Text] [Related]
13. TRIPS: generic irony.
Howarth GR
Br J Gen Pract; 2002 Jan; 52(474):57. PubMed ID: 11791819
[No Abstract] [Full Text] [Related]
14. Do patents prevent access to drugs for HIV in developing countries?
Boelaert M; Lynen L; Van Damme W; Colebunders R
JAMA; 2002 Feb; 287(7):840-1; author reply 842-3. PubMed ID: 11851568
[No Abstract] [Full Text] [Related]
15. Why are generic drugs being held up in transit? Intellectual property rights, international trade, and the right to health in Brazil and beyond.
Rosina MS; Shaver L
J Law Med Ethics; 2012; 40(2):197-205. PubMed ID: 22789040
[TBL] [Abstract][Full Text] [Related]
16. Do patents prevent access to drugs for HIV in developing countries?
Selgelid MJ; Schuklenk U
JAMA; 2002 Feb; 287(7):842-3. PubMed ID: 11851570
[No Abstract] [Full Text] [Related]
17. Do patents prevent access to drugs for HIV in developing countries?
Goemaere E; Kaninda AV; Ciaffi L; Mulemba M; t Hoen E; Pécoul B
JAMA; 2002 Feb; 287(7):841-2; author reply 842-3. PubMed ID: 11851569
[No Abstract] [Full Text] [Related]
18. Brazil and USA at loggerheads over production of generic antiretrovirals.
Ahmad K
Lancet; 2001 Feb; 357(9254):453. PubMed ID: 11273079
[No Abstract] [Full Text] [Related]
19. Canada's plan to sell generic drugs to developing countries is threatened.
Spurgeon D
BMJ; 2004 Mar; 328(7442):728. PubMed ID: 15044278
[No Abstract] [Full Text] [Related]
20. India's pharmaceutical industry: hype or high tech take-off?
Malhotra P; Lofgren H
Aust Health Rev; 2004 Nov; 28(2):182-93. PubMed ID: 15527398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
